[Form 4] SHERWIN WILLIAMS CO Insider Trading Activity

Rhea-AI Filing Summary

Sherwin-Williams (SHW) reported an insider equity grant: its SVP–CHRO received 6,060 employee stock options with an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.

The options vest in three substantially equal annual installments starting October 20, 2026, and expire on October 19, 2035. This is a standard compensation award that sets the right to buy common stock at a fixed price over time as service-based vesting conditions are met.

Insights

Corporate governance analyst

Routine Form 4: time-vested option grant with set strike.

Sherwin-Williams reported a grant of 6,060 employee stock options at an exercise price of $331.37 on October 20, 2025. The award comes from the 2025 Equity and Incentive Compensation Plan and follows a typical executive compensation structure.

The options vest annually in three equal tranches starting October 20, 2026, with an expiration on October 19, 2035. No immediate cash changes hands; value depends on future stock price relative to the strike.

As a standard equity grant to the SVP–CHRO, this filing is administrative and does not alter the company’s operating outlook. Subsequent filings may provide additional details on aggregate equity compensation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boyce Marlena K.

(Last) (First) (Middle)

101 WEST PROSPECT AVENUE

(Street)

CLEVELAND OH 44115

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP - CHRO

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$331.37	10/20/2025		A		6,060		(1)	10/19/2035	Common Stock	6,060	$0	6,060(1)	D

Explanation of Responses:

1. These options were granted on October 20, 2025, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2026, subject to vesting conditions.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Sherwin-Williams (SHW) report in this Form 4?

An executive received 6,060 employee stock options with a $331.37 exercise price on October 20, 2025.

Who is the reporting person’s role at Sherwin-Williams (SHW)?

The reporting person is an Officer, serving as SVP – CHRO.

What is the vesting schedule for the SHW options?

They vest annually in three substantially equal installments starting October 20, 2026.

When do these Sherwin-Williams options expire?

The options expire on October 19, 2035.

Under which plan were the SHW options granted?

They were granted under the 2025 Equity and Incentive Compensation Plan.

How many shares are underlying the derivative securities?

The options are exercisable for 6,060 shares of Common Stock.

Was there a price paid for the option grant itself?

The filing lists an option exercise price of $331.37 per share and a derivative price of $0 for the grant.